Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IBEX QDR

Financiado

Cerrado

IBEX QDR A Ground breaking Technological Upgrade based on Quantitative Digital...

IBEX QDR A Ground breaking Technological Upgrade based on Quantitative Digital Radiography to Exploit the Full Diagnostic Potential of Standard Digital X Ray Bone density loss is a natural process that affects us all as we age. As the loss advances, so does the risk of fracture. The lack of warning symptoms or routine tests results in a late detection of severe density loss (osteoporos... ver más

31/01/2020

IBEX INNOVATIONS L...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

IBEX INNOVATIONS LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-01-31

SMEInst-05-2016-2017: Supporting innovative SMEs in the h...

I+D

Cerrada hace 8 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IBEX INNOVATIONS LTD

1.61M€ | Lider

Proyectos interesantes

NonInvasive Cortical Bone Microstructure Analysis

Medical Technol...

Data Science

4M€ Cerrado

RTC-2016-4684-1

Medical Technol...

Data Science

199K€ Cerrado

3D RECONSTRUCTION OF THE SHAPES AND BONE MINE...

Medical Technol...

Data Science

495K€ Cerrado

BoneScreen

Medical Technol...

Data Science

150K€ Cerrado

PoCOsteo

Medical Technol...

Data Science

4M€ Cerrado

BONEQUAL

Medical Technol...

Biomedical Imag...

173K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 30 meses Fecha Inicio: 2017-07-28
Fecha Fin: 2020-01-31

Líder del proyecto

IBEX INNOVATIONS LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Bone density loss is a natural process that affects us all as we age. As the loss advances, so does the risk of fracture. The lack of warning symptoms or routine tests results in a late detection of severe density loss (osteoporosis), often when the first fracture occurs. Besides being a major social burden, in the EU it entails costs of €37 bn/year in treatment, disability or productivity loss, which could be alleviated if population-wide bone health screening methods were available. Today, measurement of bone mineral density (BMD) is only available through scarce and expensive DEXA scans, limiting testing to referred individuals grouped as high risk of osteoporosis. In response, we at IBEX Innovations have developed and patented IBEX-Quantitative Digital Radiography (IBEX-QDR). Conceived as a cost-efficient upgrade for standard digital radiography systems, it enhances the quality of digital X-ray images and enables these systems to measure BMD. All while reducing by 2-fold the X-ray dose needed to obtain the image. Altogether, IBEX QDR will unleash the diagnostic potential of digital radiology, enabling routine screening of bone density with any standard X-ray examination. In a Phase 1 project we confirmed the market opportunities for IBEX-QDR, outlined technical optimisations and achieved high-level engagement with X-ray detector and system manufacturers and healthcare providers. Now in Phase 2 we aim to reach market readiness by finalising the technological development, completing its clinical validation and securing the business aspects of the project. Once in the market, IBEX QDR will bring significant benefits for healthcare systems (early diagnosis and lower impact of ageing diseases), professionals (safer and simplified work-flows) and public health (lower radiation dose and less X-ray induced cancer). In turn, in 5 years it will provide us €16.7 million profits, 16 new people and a ROI of €9.37 per euro invested, representing c.1% of the target market.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores